Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Colorcon
Citi
Federal Trade Commission
Mallinckrodt
AstraZeneca
Cantor Fitzgerald
Boehringer Ingelheim
Farmers Insurance

Generated: May 21, 2018

DrugPatentWatch Database Preview

TECZEM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Teczem, and when can generic versions of Teczem launch?

Teczem is a drug marketed by Biovail and is included in one NDA.

The generic ingredient in TECZEM is diltiazem malate; enalapril maleate. There are twenty-six drug master file entries for this compound. Additional details are available on the diltiazem malate; enalapril maleate profile page.

US Patents and Regulatory Information for TECZEM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for TECZEM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Colorcon
Mallinckrodt
Moodys
Medtronic
US Army
UBS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.